IGM Biosciences Inc
IGMS·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$1.25
Today
-1.5%
YTD
-2.4%
About
Operating within the US, IGM Biosciences, Inc. is a biotechnology firm that researches and develops IgM antibodies for the treatment of cancer. Founded in 1993, IGM has headquarters in Mountain View, California. The company is listed on NASDAQ GS under the IGMS ticker. Chart IGMS share price movements with the help of your eToro watchlist.
Price chart
Closing price history for IGMS (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-1.39
P/S (TTM)0.54
P/B (TTM)0.76
Market cap$78.71M
Cap tierMicro-cap
Industry avg P/E-7.37
Profitability
Gross margin94.92%
EBIT margin6.96%
Net margin67.94%
ROE-47.82%
ROA-24.07%
Earnings & Revenue
Revenue (TTM)$145.05M
Revenue growth (1Y)+4882.8%
EPS (TTM)-$0.91
Free cash flow$-158.70M
Total debt$0.00
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.72
Employees149
Next earnings6 Nov '25
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.